Veradace Partners Releases Presentation Urging Tiptree Shareholders to Vote "NO" on the Problematic Proposed Sale of Fortegra to DB Insurance
Veradace's Position on Fortegra Sale: Veradace Partners L.P., a significant shareholder of Tiptree Inc., is urging shareholders to vote against the proposed sale of The Fortegra Group to DB Insurance, citing concerns over undervaluation and a flawed process that does not benefit shareholders.
Call for Restructured Deal: The firm advocates for a restructured deal that would maximize shareholder value and suggests that there are better, tax-efficient alternatives available.
Questions for the Board: Veradace has outlined critical questions for Tiptree's Board of Directors regarding the timing, pricing, and evaluation of the proposed transaction, emphasizing the need for transparency and accountability.
Disclaimer on Investment Advice: The communication from Veradace is not a solicitation for proxy votes and includes disclaimers about the reliability of the information provided, highlighting the speculative nature of forward-looking statements.
Trade with 70% Backtested Accuracy
Analyst Views on TIPT
About TIPT
About the author

Tiptree Shareholders Approve Merger Agreement with Fortegra
- Merger Approval: At the Special Meeting, approximately 81% of Tiptree shareholders voted in favor of the merger agreement with Fortegra and DB Insurance, marking a significant milestone in Tiptree's value creation and expected to enhance long-term shareholder value.
- Clear Transaction Structure: The merger will be executed through a wholly owned subsidiary of DB merging with Fortegra, ensuring a smooth transaction process and simplifying subsequent integration efforts.
- Expected Completion Timeline: Tiptree anticipates closing the merger in mid-2026, subject to customary closing conditions including necessary regulatory approvals, which will lay a foundation for future growth.
- Commitment to Transparency: Tiptree will file a Form 8-K with the SEC to report the final voting results from the Special Meeting, demonstrating the company's commitment to shareholder transparency and compliance.

Veradace Urges Tiptree Shareholders to Vote Against Fortegra Sale
- Shareholder Opposition: Veradace Partners L.P., holding 5.1% of Tiptree Inc., urges shareholders to vote against the proposed sale of Fortegra to DB Insurance at the special meeting on December 3, 2025. This proposal is viewed as a rushed deal that overlooked superior alternatives.
- Management Conflicts of Interest: Glass Lewis and Egan-Jones highlight that the deal structure raises questions about management incentives, potentially allowing management to continue siphoning value from shareholders instead of providing immediate payouts. This structure places nearly $1 billion in proceeds without a clear capital return plan, increasing shareholder risk.
- Negative Market Reaction: Following the announcement of the transaction, Tiptree's stock price dropped over 20%, indicating a lack of confidence from the market regarding the deal. Egan-Jones also noted that the deal leaves Tiptree with nearly $1 billion in unallocated cash, giving management discretion to redeploy capital at will.
- Allegations of Analytical Errors: Veradace claims that Institutional Shareholder Services' analysis contains several material errors, failing to fully assess the deal's valuation and potential risks. The conclusions drawn are seen as based on irrelevant factors, neglecting the long-term value implications for shareholders.






